1. Evaluation of miRNA 223/125a and COBLL1 Expressions and ROR-1 Levels as Reliable Markers in B- chronic Lymphocytic Leukemia

Articles in Press, Accepted Manuscript, Available Online from 09 August 2022

Samia Hussein; Abdallah S Abdelazem; Shimaa Abdelmoneem; AL-Shabrawy M Abdelnabi; Tarek Khamis; Ahmed Ali Obaya; Huda F Ebian

• View Article

2. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells

Volume 22, Issue 7, July 2021, Pages 2191-2198

Nooshin Ashofteh; Razieh Amini; Neda Molaee; Hadi Karami; Maryam Baazm

• View Article
• PDF 856.9 K

3. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population

Volume 20, Issue 5, May 2019, Pages 1579-1585

Ameen Abdulaziz Mohammed Basabaeen; Enaam Abdalrhman Abdelgader; Ebtihal Ahmed Babekir; Saadia Osman Abdelrahim; Nada Hassan Eltayeb; Osama Ali Altayeb; Eman Abbass Fadul; Abdulwali Sabo; Ibrahim Khider Ibrahim

• View Article
• PDF 437.5 K

4. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms

Volume 19, Issue 12, December 2018, Pages 3383-3392

Neveen Bahaa El Din Fouad; Noha Yehia Ibrahim; Rania Salah Abdel Aziz; Sarah Khalid Ibrahim

• View Article
• PDF 524.85 K

5. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia

Volume 18, Issue 12, December 2017, Pages 3245-3250

Yasser B.M Ali; Rasha M Foad; Essam Abdel-Wahed

• View Article
• PDF 407.75 K

6. Lack of Association of the NPAS2 Gene Ala394Thr Polymorphism (rs2305160:G>A) with Risk of Chronic Lymphocytic Leukemia

Volume 15, Issue 17, December 2014, Pages 7169-7174

• View Article
• PDF 471.8 K

7. Chronic Lymphocytic Leukemia at Recent 10 Years and Treatment Effects of Fludarabin

Volume 8, Issue 3, March 2007, Pages 367-371

• View Article
• PDF 48.23 K